Syndecan-1/CD138 Antibody (B-A38) | Novus Biologicals NB100-64980-100ug product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Novus Biologicals

other brands :

IMGENEX

product type :

antibody

product name :

Syndecan-1/CD138 Antibody (B-A38)

catalog :

NB100-64980-100ug

quantity :

100 ug (also 0.02 mg)

price :

449 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

B-A38

reactivity :

human

application :

western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section

citations: 15

Reference
Lin S, Wu C, Tseng T, Jhang Y, Lee S. Role of syndecan-1 and exogenous heparin in hepatoma sphere formation. Biochem Cell Biol. 2019;: pubmed publisher
Sharpe B, Alghezi D, Cattermole C, Beresford M, Bowen R, Mitchard J, et al. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells. Prostate. 2017;77:1312-1324 pubmed publisher
Wang C, Tseng T, Jhang Y, Tseng J, Hsieh C, Wu W, et al. Loss of cell invasiveness through PKC-mediated syndecan-1 downregulation in melanoma cells under anchorage independency. Exp Dermatol. 2014;23:843-9 pubmed publisher
Li K, Tipps A, Wang H. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting as an isolated nasopharyngeal mass: a case report and review of literature. Int J Clin Exp Pathol. 2010;4:190-6 pubmed
Beauvais D, Rapraeger A. Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation. J Cell Sci. 2010;123:3796-807 pubmed publisher
Thaunat O, Patey N, Caligiuri G, Gautreau C, Mamani Matsuda M, Mekki Y, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol. 2010;185:717-28 pubmed publisher
Du S, Rashidi H, Le D, Kipps T, Broome H, Wang H. Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma. Int J Clin Exp Pathol. 2010;3:448-57 pubmed
Chang H, Jiang N, Jiang H, Saha M, Qi C, Xu W, et al. CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma. Haematologica. 2010;95:1542-7 pubmed publisher
Kim Y, Ko Y, Hong S, Kim K, Lee Y, Chae C, et al. Presence of Porphyromonas gingivalis and plasma cell dominance in gingival tissues with periodontitis. Oral Dis. 2010;16:375-81 pubmed publisher
Kylanpaa L, Hagstrom J, Lepistö A, Linjama T, Kärkkäinen P, Kiviluoto T, et al. Syndecan-1 and tenascin expression in cystic tumors of the pancreas. JOP. 2009;10:378-82 pubmed
Beauvais D, Ell B, McWhorter A, Rapraeger A. Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med. 2009;206:691-705 pubmed publisher
Mahshid Y, Lisy M, Wang X, Spanbroek R, Flygare J, Christensson B, et al. High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes. BMC Immunol. 2009;10:2 pubmed publisher
Yang Y, Macleod V, Dai Y, Khotskaya Sample Y, Shriver Z, Venkataraman G, et al. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood. 2007;110:2041-8 pubmed
Guedez L, Martinez A, Zhao S, Vivero A, Pittaluga S, Stetler Stevenson M, et al. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. Blood. 2005;105:1660-8 pubmed
Anttonen A, Kajanti M, Heikkila P, Jalkanen M, Joensuu H. Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer. 1999;79:558-64 pubmed

product information

brand :

Novus Biologicals, a Bio-Techne Brand

catalog number base :

NB100-64980

SKU :

NB100-64980-100ug

product name :

Syndecan-1/CD138 Antibody (B-A38)

Description :

The Syndecan-1/CD138 Antibody (B-A38) from Novus is a mouse monoclonal antibody to Syndecan-1/CD138. This antibody reacts with human. The Syndecan-1/CD138 Antibody (B-A38) has been validated for the following applications: Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.

target :

Syndecan-1/CD138

category :

Primary Antibodies

unit size :

100 ug (also 0.02 mg)

buffer :

PBS, 1% BSA

clonality :

Monoclonal

clone :

B-A38

concentration :

0.1 mg/ml

conjugate :

Unconjugated

host :

Mouse

immunogen :

U266 cell line

isotype :

IgG1

purity :

Protein G purified

species :

Human

specificity :

NB100-64980 recognizes a heparan sulfate rich membrane glycoprotein of 200kD known as Syndecan-1 (CD138)

gene symbol :

SDC1

accessionNumbers :

P18827

applications :

Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen

extended description :

Clone B-A38 was used by HLDA to establish CD designation.

USD :

449 USD

product details :

Clone B-A38 was used by HLDA to establish CD designation.

alt names :

CD138, CD138 antigen, SDC, SYND1heparan sulfate proteoglycan fibroblast growth factor receptor, syndecan, syndecan 1, syndecan proteoglycan 1, syndecan-1

storage :

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.